Vincristine sulfate as a possible cause of optic neuropathy.
A 6-year-old boy with skin lesions suggestive of neurofibromatosis developed a frontotemporal primitive neuroectodermal tumor and was subsequently treated with surgery, craniospinal irradiation, and chemotherapy. After the sixth cycle of treatment with vincristine sulfate, 9 months after diagnosis, the child developed a rapidly progressive bilateral deterioration in visual acuity. Retinal appearances were consistent with optic neuropathy. Gene studies for neurocutaneous syndromes were negative. Brain imaging at this time showed no tumor progression, and in the absence of other etiologies, we implicate vincristine as a probable cause. Discontinuation of this particular agent has allowed bilateral improvement in visual acuity.
Weisfeld-Adams
James D
JD
Departments of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Glasgow, United Kingdom. jamesweisfeldadams@hotmail.com
Dutton
Gordon N
GN
Murphy
Dermot M
DM
D002648:Child; D006801:Humans; D008297:Male; D018241:Neuroectodermal Tumors, Primitive, Peripheral / Q000628:therapy; D009901:Optic Nerve Diseases / Q000139:chemically induced*; D014750:Vincristine / Q000009:adverse effects*
D014750:Vincristine